نتایج جستجو برای: zafirlukast

تعداد نتایج: 158  

Journal: :Pharmacotherapy 2002
Dev S Pathak E Anne Davis Richard H Stanford

STUDY OBJECTIVE To compare asthma-related health care expenditures among patients newly prescribed fluticasone propionate 44 or 110 microg, montelukast 5 or 10 mg, or zafirlukast 20 mg. DESIGN Retrospective cohort analysis of medical and pharmacy claims. SETTING University-affiliated health outcomes research center. PATIENTS Seven hundred eighty-one patients (aged > or = 4 yrs) with asthm...

Journal: :medical journal of islamic republic of iran 0
seyed ali javad moosavi pulmonologist, rasoul-e-akram hospital, tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)سازمان های دیگر: rasoul-e-akram hospital, hanieh raji department of internal medicine, faculty of medicine, jundishapur university of medical sciences, ahvaz, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی جندی شاپور اهواز (ahvaz jundishapur university of medical sciences) baharak tasorian tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences) elyas mostafapour student scientific research committee, tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences) shahab shahabi isfahan university of medical sciences, isfahan, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی اصفهان (isfahan university of medical sciences) mohammad purfakharan , tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)

background : there is little evidence about the role of zafirlukast (a highly selective ltd4 antagonist) in chronic obstructive pulmonary disease (copd). the zafirlukast can reduce the need for short-acting rescue β2 agonists, produce fewer exacerbations of asthma and increased quality of life as possible benefits treatment for asthma. the aim of our study was to evaluate the effects of zafirlu...

Journal: :Chest 2004
Robert A Silverman Richard M Nowak Phillip E Korenblat Emil Skobeloff Yusong Chen Catherine M Bonuccelli Christopher J Miller Steven G Simonson

CONTEXT Acute asthma causes nearly 2 million hospital emergency department (ED) visits in the United States annually, and hospitalization after an ED visit and relapse after ED discharge are common. OBJECTIVE To evaluate the adding of therapy with zafirlukast to standardized care for patients with acute asthma in the ED and a 28-day follow-up period. DESIGN AND PATIENTS A total of 641 patie...

Journal: :American journal of rhinology 2007
Ching-Yin Ho Ching-Ting Tan

BACKGROUND The aim of this study was to compare the effect of antileukotriene (anti-LT), antihistamine, and a combination of anti-LT and antihistamine on the symptoms and nasal resistance in allergic rhinitis patients. METHODS We performed a placebo-controlled study, with 120 persistent, moderate to severe allergic rhinitis patients randomly selected to receive the different treatments for 4 ...

Journal: :Sexually transmitted infections 2004
D J White A Vanthuyne P M Wood J G Ayres

BACKGROUND Recurrent vulvovaginal candidiasis (VVC) has been linked to allergic disease, particularly allergic rhinitis. OBJECTIVE A pilot study to assess the possible use of the leukotriene receptor antagonist zafirlukast as a treatment for recurrent VVC. METHODS 20 women with six or more symptomatic attacks of VVC in the past year (at least four proved microbiologically). Clinical atopy d...

Journal: :Aesthetic surgery journal 2005
Russell R Reid Susan D Greve Laurie A Casas

BACKGROUND The development of capsular contracture following breast augmentation presents a challenge to the plastic surgeon. Treatment of capsular contracture with the leukotriene antagonist zafirlukast (Accolate, AstraZeneca, Wayne, PA) has received much attention in the media; however, there is limited proof of its effectiveness. OBJECTIVE The purpose of this study was to prospectively exa...

Journal: :Molecular pharmacology 1999
H M Sarau R S Ames J Chambers C Ellis N Elshourbagy J J Foley D B Schmidt R M Muccitelli O Jenkins P R Murdock N C Herrity W Halsey G Sathe A I Muir P Nuthulaganti G M Dytko P T Buckley S Wilson D J Bergsma D W Hay

The cysteinyl leukotrienes (CysLTs) have been implicated in the pathophysiology of inflammatory disorders, in particular asthma, for which the CysLT receptor antagonists pranlukast, zafirlukast, and montelukast, have been introduced recently as novel therapeutics. Here we report on the molecular cloning, expression, localization, and pharmacological characterization of a CysLT receptor (CysLTR)...

Journal: :The New England journal of medicine 2005
Homer A Boushey Christine A Sorkness Tonya S King Sean D Sullivan John V Fahy Stephen C Lazarus Vernon M Chinchilli Timothy J Craig Emily A Dimango Aaron Deykin Joanne K Fagan James E Fish Jean G Ford Monica Kraft Robert F Lemanske Frank T Leone Richard J Martin Elizabeth A Mauger Gene R Pesola Stephen P Peters Nancy J Rollings Stanley J Szefler Michael E Wechsler Elliot Israel

BACKGROUND Although guidelines recommend daily therapy for patients with mild persistent asthma, prescription patterns suggest that most such patients use these so-called controller therapies intermittently. In patients with mild persistent asthma, we evaluated the efficacy of intermittent short-course corticosteroid treatment guided by a symptom-based action plan alone or in addition to daily ...

2015
Shin Hyuk Kang Kee Cheol Shin Woo Seob Kim Tae Hui Bae Han Koo Kim Mi Kyung Kim

BACKGROUND Capsular contracture is the most troublesome complication in breast implant surgery. Although capsule formation can be seen as a normal reaction to a foreign body, it can induce pain, hardness, deformity, and other pathologic problems. Surgical intervention is required in severe cases, but even surgery cannot guarantee a successful outcome without recurrence. This experimental study ...

Journal: :Journal of immunology 2010
Grzegorz Woszczek Li-Yuan Chen Sara Alsaaty Sahrudaya Nagineni James H Shelhamer

The use of cysteinyl leukotriene receptor antagonists (LTRAs) for asthma therapy has been associated with a significant degree of interpatient variability in response to treatment. Some of that variability may be attributable to noncysteinyl leukotriene type 1 receptor (CysLT(1))-mediated inhibitory mechanisms that have been demonstrated for this group of drugs. We used a model of CysLT(1) sign...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید